NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Developing Treatments to Fight Lung Cancer

Related Editorial
After thirty years of development, gene therapy is seeing a surge of progress and profitability.

Gene therapies tackle diseases by altering the genetic makeup of patients’ cells. Recent mergers and research developments make this a promising time to invest in the sector. Gene therapy companies are developing treatments for everything from cancer and HIV to skin diseases.

Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is developing treatments to tackle lung cancer. Spark Therapeutics Inc. (NASDAQ: ONCE), which recently entered a merger agreement with the Roche Group, targets ailments such as retinal and neurodegenerative diseases. Dyadic International Inc. (OTCQX: DYAI) is focused on finding uses for a fungal-based technology that could bring treatments to market faster. TrovaGene Inc. (NASDAQ: TROV) uses cell-level treatments to tackle cancer through inhibiting a specific enzyme. The technology developed by Novartis AG (NYSE: NVS) uses specific viruses to deliver treatment for a range of illnesses.

To view the full editorial, visit http://nnw.fm/2yq0K

To hear the NetworkNewsAudio version, visit http://nnw.fm/bw1cX

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

About NetworkNewsAudio

NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.

For more information, visit www.NetworkNewsAudio.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

More Press Releases

In Cannes, Terrence Malick uncovers 'A Hidden Life'

May 21, 2019

CANNES, France — "Where's Terrence Malick?" It's a familiar question for the famously press-shy filmmaker that was, predictably, hollered again Monday at the Cannes Film Festival. Malick, whose "Tree of Life" won the Palme d'Or in 2011, returned to the French festival with a movie whose title could double for a description of the seldom-seen director himself: "A Hidden Life." The film, based on the true story of an Austrian conscientious objector to Adolf Hitler's army in World War II, premiered Sunday night in Cannes where Malick was, in fact, in attendance. Though he eluded the festival's red carpet photographers,...

'John Wick 3' dethrones 'Avengers: Endgame' with $57 million

May 21, 2019

LOS ANGELES — The box office has a new king and his name is John Wick. The third installment of the hyper violent Keanu Reeves franchise has taken the top spot at the North American box office and ended the three-week reign of "Avengers: Endgame." Studios on Sunday say "John Wick: Chapter 3 — Parabellum" has grossed an estimated $57 million in its opening weekend. "Avengers: Endgame" slid to second place in its fourth weekend with $29.4 million. Domestically, it's now second only to "Star Wars: The Force Awakens." "Pokémon Detective Pikachu" placed third with $24.8 million and "A Dog's...

On two wheels, 'The Climb' rides through Cannes as a hit

May 21, 2019

CANNES, France — One of the breakouts at the Cannes Film Festival is a comedy about a male friendship that developed over many years and hundreds of miles on their bikes. Michael Angelo Covino's "The Climb" has been one of the most acclaimed American films in Cannes, even though it's just Covino's first feature. With fluid long takes, it captures comic moments in a lifelong friendship. It begins with a bike ride in France in which one rider, mid-hill, tells the other that he's slept with his fiancee. Covino and his co-star Kyle Marvin shot their opening scene in France...

Actor-comedian Sammy Shore, father of Pauly, dies at 92

May 21, 2019

LAS VEGAS — Sammy Shore, an actor and standup comedian who co-founded the Comedy Store, died Saturday. He was 92. Through a spokeswoman, Shore's family said he died at his Las Vegas home surrounded by family. He was the father of actor-comedian Pauly Shore. Shore's nearly seven-decade career stretched from the "Borscht Belt" summer resorts of New York's Catskill Mountains to Las Vegas to the studios of Hollywood. Shore began his career doing standup with Shecky Greene. Elvis Presley chose Shore as the opening act for his comeback tour, and the comedian opened for many others, including Tony Orlando, Barbra...

A newly restored 'The Shining' debuts in Cannes

May 21, 2019

CANNES, France — Alfonso Cuaron has introduced a restoration of Stanley Kubrick's "The Shining" at the Cannes Film Festival. The Mexican filmmaker was notably absent from Cannes last year when his "Roma" was expected to premiere here. But when Netflix and the festival couldn't agree on distribution terms for the streaming giant's films, "Roma" instead headed to the Venice Film Festival where it won the Golden Lion. This time, Cuaron helped debut a 4K restoration of Kubrick's 1980 horror masterpiece that was overseen by Steven Spielberg. In a premiere Friday night, Cuaron was joined by Kubrick's daughter, Katharina Kubrick, and...

Broaden News

Reporter Pass is the only access you need to get into Hollywood. No matter it’s the red carpet event or backstage access, we’ve got you covered.

Contact us: sales@reppass.com

Award ShowsCelebrityPaparazziRoyaltyMoviesMusicTelevision Programs Press Releases